43 results on '"Kim, Hee Nam"'
Search Results
2. Prognostic Impact of DNA Repair and MDR-1 Gene Polymorphisms In De Novo Acute Myeloid Leukemia with t(8;21) or Inv(16)
3. Implication of Genetic Variations of Ikzf1, ARIDB5, and CEBPE Genes In the Risk of Childhood Acute Lymphoblastic Leukemia In Korea
4. Clinical Significance of Polymorphisms During Hepatopoietic Stem Cell Transplantation.
5. Genome-Wide Screening of Copy Number Variation In Childhood Neuroblastoma
6. Genome-Wide Detection of Copy Number Variation and Identification of Genes Associated with Risk of Multiple Myeloma
7. Prognostic Significances of ABCG-2 and hOCT-1 Gene Expression in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate.
8. DNA Methylation Changes Following 5-Azacitidine Treatment in Patients with Myelodysplastic Syndrome.
9. The Prohibitin 3′ Untranslated Region Polymorphisms Are Associated with AML Susceptibility.
10. Association Between Genetic Polymorphism in DNA Repair Genes and Acute Myeloid Leukemia.
11. Genome-Wide DNA Methylation Analysis of Patients with Myelodysplastic Syndrome After Azacitidine Treatment.
12. Prognostic Significance of NQO1 Polymorphism and GST-M1 Deletion in De Novo Acute Myeloid Leukemia
13. GST T1 and GST M1 Polymorphisms Are Associated with the Risk of Acute Myeloid Leukemia
14. Prognostic Significance of hOCT1 and ABCG2 Expression in Chronic Myeloid Leukemia Patients Treated with Imatinib
15. Polymorphisms in Myeloid Cell Leukemia-1 and the Risk for Acute Myeloid Leukemia
16. Discovery of a New Molecular Marker, Prohibitin, and Development of Candidates for New Chemotherapeutic Agents Targeting Prohibitin in Primary AML Cells.
17. Allelic Expression Imbalance of JAK2 V617F Mutant Contributes to Phenotypic Variation in BCR-ABL Negative Chronic Myeloproliferative Disorders.
18. Case-Control Study Using Array-Based Genotyping Produced a Panel of Genes Associated with Risk to Acute Myelogenous Leukemia (AML).
19. No Reversal of Demethylation after Azacitidine Treatment in Concordance with Poor Clinical Response.
20. Identification of Genes Associated with Risk to Aplastic Anemia (AA) Using Array-Based Genotyping.
21. Functional Polymorphisms of Notch 4 and the Risk of Aplastic Anemia.
22. Prognostic Significance of ABCB1 (MDR1) Gene Polymorphisms in De Novo Acute Myeloid Leukemia with t(8;21) or inv(16).
23. Prognostic Significance of FLT3/ITD Mutation in AML1/ETO-Associated Acute Myeloid Leukemia.
24. Notch 4 Plymorphism Associated with Risk of Aplastic Anemia.
25. Evolution of FLT3 Internal Tandem Duplication at the Diagnosis, Relapse, Remission or Induction Failure during the Treatment in Acute Myeloblastic Leukemia.
26. High-Sensitivity Mutational Analysis of BCR-ABL Mutations in the Kinase Domain Using Pyrosequencing Could Provides Alternative Methodology for Monitoring the Proportion of Mutant Alleles in Patient with Chronic Myelogenous Leukemia.
27. Association of cis-Acting rs530 of the ETS2 Transcriptional Factor Gene with High-Risk Acute Myelogenous Leukemia (AML) and Allelic Expression Imbalance Assessment.
28. Polymorphisms of Thymidylate Synthase in the 5′- and 3′-Untranslated Regions Associated with Risk of Non-Hodgkin’s Lymphoma.
29. Two Single Nucleotide Polymorphisms of the ETS2 Transcriptional Factor Gene Predispose Individuals to High-Risk Acute Myelogenous Leukemia (AML).
30. A Single Nucleotide Polymorphism and Its Haplotype of ZNF42 Transcriptional Modulator Gene Predisposes Individuals to High-Risk Acute Myelogenous Leukemia (AML).
31. Interluekin-10 (IL-10) Promoter Gene Polymorphism (−819*C) Associated with Poor Clinical Outcome in DLBCL Patients Treated with R (Rituximab)-CHOP Regimen as a First Line.
32. Denaturing- HPLC and HR-1 Melter-Based Detection of ABL Mutations in Patients with Chronic Myelogenous Leukemia (CML).
33. The Feasibility Study for Using FLT3/ITD as a Marker of the Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) by Serial Analysis in Diagnosis, Remission and Relapse.
34. The Presence of FLT3/ITD Mutations Is an Independent Prognostic Factor in Acute Myeloid Leukemia Patients with Normal Karyotype.
35. Prognostic Relevance of Gene Expression Using RT-PCR in Diffuse Large B-Cell Lymphoma.
36. Biological Significance and Profile of Length Heteroplasmy in the Hypervariable Segments of the Human Mitochondrial DNA Control Regions from Blood Cells.
37. Clinical Significance of FLT3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia Who Underwent Allogeneic Bone Marrow Transplantation.
38. Copy Number Alterations of PAX5, CDKN2A/BGenes Rather Than IKZF1gene Are Associated with Pathogenesis of Childhood ALL in Korean Assessed by Multiplex Ligation-Dependent Probe Amplification
39. Implication of Genetic Variations of Ikzf1, ARIDB5, and CEBPEGenes In the Risk of Childhood Acute Lymphoblastic Leukemia In Korea
40. The Prohibitin3′ Untranslated Region Polymorphisms Are Associated with AML Susceptibility.
41. Allelic Expression Imbalance of JAK2V617F Mutant Contributes to Phenotypic Variation in BCR-ABL Negative Chronic Myeloproliferative Disorders.
42. Prognostic Significance of ABCB1(MDR1) Gene Polymorphisms in De Novo Acute Myeloid Leukemia with t(8;21) or inv(16).
43. Two Single Nucleotide Polymorphisms of the ETS2Transcriptional Factor Gene Predispose Individuals to High-Risk Acute Myelogenous Leukemia (AML).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.